IDEA Bio-Medical's Sells HCS system to Virginia Commonwealth University in Richmond, VA

Rehovot, Israel, and Richmond, VA, August 7, 2013:


IDEA Bio-Medical and Virginia Commonwealth University (VCU) announced today that they have completed the sale of IDEA Bio-Medical’s breakthrough Hermes WiScan® system to the Department of Neurosurgery in the Massey Cancer Center.


This revolutionary, High-Definition, Automated Cell-Imaging system was designed to serve biomedical scientists that do not necessarily have expertise in microscopy systems.  The system operates at extremely high speeds of image acquisition, and generates very high quality images.  It's a wide field fluorescence and bright field microscope, that uses a patented, laser-based autofocus technology to very rapidly identify the image location and focus on it, using various magnifications.  The system is best suited for multi-well cell-based assays, run automatically or manually, but can also be used with other sample formats.  It's the optimal combination of image quality, speed, ease-of-use, and price. 


“Two years ago we were pretty much unknown.  Today we have systems installed in the Southeast and Northeast US, in the United Kingdom, France and Germany, and in Israel.  We will soon be announcing additional sales in Germany, the Czech Republic and neighboring countries, and in China.  We're thrilled about VCU's interest, and look forward to supporting their research efforts going forward,” said Ilan Friedman, Manager of Global Sales and Distribution Channels for IDEA Bio-Medical.

"The decision to purchase Hermes was based on our wish to both expand our core in vitro assays for high throughput screening in an easy to use automated microscope, but also to develop standardized assays for assessment of the chemo-sensitivity of primary tumor sections from patients. The Hermes machine will permit us in the long term to develop, in real time, an assay for patients that could permit a choice of therapies based on the biology of their own specific tumor," said Prof. Paul Dent, Vice Chair of the Department of Neurosurgery.

WiScan® technology originated at Israel's Weizmann Institute of Science and at IDEA Bio-Medical’s parent company IDEA Machine Development, and was further developed by IDEA Bio-Medical as part of a commercialization agreement with YEDA – the Institute’s technology transfer arm.


About the Department of Neurosurgery at VCU

The Harold F. Young Neurosurgical Center is a recognized provider of comprehensive services whose mission is to integrate clinical research with patient services while training future clinicians and scientists.  VCU emphasizes the systematic study and treatment of head injuries. Since 1985, Dr. Harold Young, Chair of the Department of Neurosurgery, has continued the tradition of clinical and basic scientific investigation in traumatic brain injury while reinforcing the department’s original dedication to clinical excellence and resident education.  Under his leadership, the Neurosurgery department generated more than $25 million in sponsored research from the National Institutes of Health. For more information, visit

early abortion pill termination pregnancy pill abortion experiences
my spouse cheated on me now what click want to cheat on my wife
lamictal depresija lamictal 25 mg lamictal depresija